本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

6.73
-0.1900-2.75%
盤後6.72-0.0100-0.15%16:43 EDT
成交量:129.42萬
成交額:881.38萬
市值:6.96億
市盈率:-3.80
高:7.01
開:6.92
低:6.59
收:6.92
52周最高:9.54
52周最低:4.73
股本:1.03億
流通股本:7,991.55萬
量比:1.98
換手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
淨資產收益率:-53.49%
總資產收益率:-31.24%
市淨率:2.21
市盈率(LYR):-3.82

資料載入中...

2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/08

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933